Hot Asian Stocks To Invest In Right Now

European stocks were little changed as investors weighed German data that showed business confidence in Europe�� largest economy increased to the highest level since April 2012. U.S. index futures and Asian shares were also little changed.

Novartis AG climbed 1.5 percent after proposing a share buyback and saying it will enter new business segments. Solarworld AG rallied 6.1 percent after a report that it will announce the takeover of Bosch Solar Energy AG next week. Rhoen-Klinikum AG fell 2.9 percent after saying its second-biggest shareholder sued to block the sale of 43 clinics to Fresenius SE�� Helios unit.

The Stoxx Europe 600 Index gained 0.1 percent 322.83 at 10:29 a.m. in London. The benchmark gauge has lost 0.1 percent this week as Federal Reserve minutes signaled policy makers may reduce stimulus sooner than investors predicted. Standard & Poor�� 500 Index futures added less than 0.1 percent today, while the MSCI Asia Pacific Index increased 0.1 percent.

Hot Net Payout Yield Companies To Watch In Right Now: OXiGENE Inc.(OXGN)

OXiGENE, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics to treat cancer and eye diseases in the United States. It primarily focuses on the development of vascular disrupting agents (VDAs) that disable and destroy abnormal blood vessels, which provide solid tumors a means of growth and survival, as well as associate with visual impairment in various ophthalmological diseases and conditions. The company?s products include ZYBRESTAT, which is in fosbretabulin in anaplastic cancer of the thyroid (FACT) trial?Phase 2/3 study for the treatment of anaplastic thyroid cancer; in fosbretabulin in advanced lung oncology (FALCON) trial?Phase 2 randomized and controlled study to treat non-small cell lung cancer; in Phase 2 Simon two-stage design study for the treatment of platinum-resistant ovarian cancer; and in Phase 2 randomized controlled study to treat platinum-relapsed but platinum sensitive ovarian cancer. Its products also comprise OXi4503 that is in Phase 1 dose-escalation study for the treatment of acute myelogenous leukemia and myelodysplastic syndromes; Phase 1b dose-ranging study to treat solid tumors with hepatic tumor burden; and Phase 1 dose-escalation study for the treatment of refractory solid tumors. In addition, the company?s products consist of ZYBRESTAT, which is in Phase 2 randomized, double-masked, placebo-controlled, single-dose study for proof-of-mechanism study in polypoidal choroidal vasculopathy. OXiGENE has a strategic collaboration agreement with Symphony Capital Partners, L.P. to support the advancement of ZYBRESTAT for oncology and ophthalmology, and OXi4503. The company was founded in 1988 and is headquartered in South San Francisco, California.

Advisors' Opinion:

• [By Bryan Murphy]

  For the second time in as many days, I find myself supporting the purchase of a suddenly-bullish stock by saying "this time is different". Yesterday I was talking about OXiGENE Inc. (NASDAQ:OXGN), but today I'm using the term to describe the bullishness that's unfurling with Neurometrix Inc. (NASDAQ:NURO). And just for the record, yes, I know the perils of the "this time is different" argument. I tend to cringe when I hear it, as (too much) experience has taught me that things are rarely different - patterns within the market play themselves out over and over again. In the case of NURO as well as OXGN though, I can put my finger on something specific that we've not yet seen.

• [By Bryan Murphy]

  If you missed the recent surges from Neurometrix Inc. (NASDAQ:NURO) and/or OXiGENE Inc. (NASDAQ:OXGN), and decided to skip an entry on either or both because they were too frothy at the time, then here's some good news.... you're getting a second chance. Both NURO and OXGN are getting their proverbial second wind, and they're doing so at a price much lower than the price you would have had to pay for either just a few days ago. There's just one catch - you may want to hurry of you want in. This second wind is unfurling as rapidly as the first surges did.

• [By Bryan Murphy]

  There's no denying that OXiGENE Inc. (NASDAQ:OXGN) has, if nothing else, an interesting pipeline. And for many investors, the prospect of one or two budding winners in development is more than enough reason to jump into a biotech stock. In the case of OXGN, however, there's a far more direct - and no less speculative - reason to become a shareholder. That reason? The stock's going higher.... seriously.

• [By Wallace Witkowski]

  Shares of Oxigene Inc. (OXGN) �more than doubled on very heavy volume after the microcap biotech said a mid-stage study of its drug Zybrestat, when used with Roche�� Avastin, showed increased survival in ovarian cancer patients. Oxigene shares rallied 129% to $5.55 , and were one of the most heavily traded issues after hours with more than 4.2 million shares exchanging hands.

Hot Asian Stocks To Invest In Right Now: 7 Days Group Holdings Limited(SVN)

7 Days Group Holdings Limited, through its subsidiaries, operates a chain of limited service economy hotels under the brand name of 7 Days Inn in China. The company provides accommodations and services primarily to business and leisure travelers. As of December 31, 2010, it operated 568 hotels in operation, including 247 managed hotels, with 56,410 hotel rooms in 89 cities, as well as 197 hotels with 19,345 hotel rooms under conversion. The company was founded in 2004 and is based in Guangzhou, China.

Advisors' Opinion:

• [By Rich Duprey]

  Chinese economy hotel chain 7 Days Group (NYSE: SVN  ) announced today that the company's shareholders had approved the going-private proposal that was offered up on Feb. 28.�Approximately 88.3% of the hotel chain's shares voted on the proposal, and approximately 86% voted in favor of it.�

Hot Asian Stocks To Invest In Right Now: Rosetta Stone(RST)

Rosetta Stone Inc., together with its subsidiaries, provides technology-based language-learning solutions in the United States and internationally. The company develops, markets, and sells language-learning solutions, such as software, online services, mobile applications, and audio practice tools in approximately 30 languages primarily under the Rosetta Stone brand. Its products and services include Rosetta Course, a self-study interactive language-learning curriculum that consists of sequences of listening, speaking, reading, and writing interactions designed to teach, reinforce, and test learners through its software program; Rosetta Studio comprising a series of coach-led practice sessions that provide learners to practice what they have previously learned through the software program; and Rosetta World, an interactive community of language learners, which gives learners the opportunity to play games with other learners. The company also offers Audio Companion, which i s a series of digital audio files that contain lessons aligned to the Rosetta Stone curriculum, allowing users to practice previously learned material; and TOTALe Companion HD, a learning tool that includes a series of practice lessons, which use images, audio, and speech recognition technology to enable users refine their speaking skills. The company also offers SharedTalk, an online peer-to-peer practice environment at sharedtalk.com; and ReFLEX, a solution designed for English learners who want to enhance listening and speaking skills. Rosetta Stone sells its products and services through Websites, call centers, retailers, direct sales force, and a network of kiosks. Its customers include individuals, home school parents, educational institutions, armed forces, government agencies, corporations, and not-for-profit institutions. Rosetta Stone Inc. was founded in 1992 and is headquartered in Arlington, Virginia.

Advisors' Opinion:

• [By Matthew Argersinger]

  The following video excerpt was taken from an interview with Steve Swad, CEO of Rosetta Stone (NYSE: RST  ) , in which he talks about his business philosophy and how it is driving success both for language learners and for the company itself. In this segment, he discusses how his products are helping people learn through technology.

• [By Brian Stoffel]

  From these five, I will be purchasing shares of Rosetta Stone� (NYSE: RST  ) , as soon as Foolish trading rules allow. Read below to see what I expect from the company moving forward, and what I'll need to see to determine if my investment will succeed.

Hot Asian Stocks To Invest In Right Now: Blackrock Enhanced Equity Dividend Trust (BDJ)

BlackRock Enhanced Dividend Achievers Trust (the Trust) is a diversified closed-end management investment company. The Trust�� primary investment objective is to seek current income and current gains, with a secondary objective of long-term capital appreciation. The Trust seeks to achieve these objectives by investing in common stocks that pay above average dividends and have the potential for capital appreciation and by utilizing an option writing strategy to enhance distributions paid to the Trust�� shareholders.

Under normal market conditions, the Trust will invest at least 80% of its total assets in common stocks that are included in the universe of common stocks of issuers, which Mergent has determined are Dividend Achievers and options with exposure to such stocks. From time to time, the Trust may invest up to 20% of its total assets in investments without exposure to the Dividend Achievers universe. As part of its investment strategy, the Trust intends to employ a strategy of writing (selling) covered call and put options on individual common stocks, indices of securities, sectors of securities and baskets of securities.

Advisors' Opinion:

• [By Robert Hsu]

  Here are four to consider:

  PowerShares S&P 500 BuyWrite ETF (PBP), yielding 4.09%
  
  Madison/Claymore Covered Call & Equity Strategy (MCN), yielding 8.94%
  
  Nuveen Equity Premium Opportunity Fund (JSN), yielding 9.19%
  
  BlackRock Enhanced Dividend Achievers (BDJ), yielding 7.39%
  
  

  The yield on these funds is very attractive. Even more attractive is the fact that many buy-write funds actually are selling at a discount to their net asset value.

Hot Asian Stocks To Invest In Right Now: Australian Dollar(AU)

AngloGold Ashanti Limited primarily engages in the exploration and production of gold. It also produces silver, uranium oxide, and sulfuric acid. The company conducts gold-mining operations in South Africa; continental Africa, including Ghana, Guinea, Mali, Namibia, and Tanzania; Australia; and the Americas, which include Argentina, Brazil, and the United States. It also has mining or exploration operations in the Democratic Republic of the Congo, Guinea, and Colombia. As of December 31, 2010, the company had proved and probable gold reserves of 71.2 million ounces. The company has a strategic alliance with Thani Dubai Mining Limited to explore, develop, and operate mines across the Middle East and parts of North Africa. AngloGold Ashanti Limited, formerly known as Vaal Reefs Exploration and Mining Company Limited, was founded in 1944 and is headquartered in Johannesburg, South Africa.

Advisors' Opinion:

• [By Dan Caplinger]

  We've seen the flip side of that trend play out in recent years, as rock-bottom interest rates in the U.S. have encouraged investment in higher-yielding income investments in places like Australia, Brazil, and South Africa. Interest from foreign investors got to be so extensive in Brazil that the federal government imposed a tax on foreign investors in bonds in order to curb demand and slow the pace of the Brazilian real's appreciation. Exchange-rate issues also likely played a role in the health of the commodities markets, as mining giants BHP Billiton (NYSE: BHP  ) and Rio Tinto (NYSE: RIO  ) in Australia benefited from increased demand largely for base metals. Similarly, South African gold miners AngloGold Ashanti (NYSE: AU  ) and Gold Fields (NYSE: GFI  ) outperformed rivals from elsewhere in the world, benefiting from strength in the South African rand currency.

• [By Brianna Valleskey]

  The result is that gold producers are not a particularly exciting part of markets in South Africa anymore, Theron said. Most of the large gold companies, like AngloGold Ashanti Limited (NYSE: AU) and Gold Fields Limited (NYSE: GFI), have internationalized their operations, he said, but still have a footprint in South Africa.

• [By Daniel Putnam]

  First, and most important, earnings estimates are stabilizing. In the past sixty days, 2013 estimates for the major gold miners have begun to tick up. In most cases, the increase is very modest. For instance, Goldcorp‘s (GG) EPS estimates have climbed from $0.91 to $0.95, while Barrick Gold‘s (ABX) have inched up from $2.57 to $2.64. Newmont Mining (NEM), Anglogold Ashanti (AU), and Gold Fields Ltd. (GFI) have shown similar gains. This positive rate of change marks a significant departure from the steady stream of bad news investors have had to endure in recent years.

• [By Jim Powell]

  In addition to holding Goldcorp and Barrick Gold, the fund tracks the performance of Newmont Mining (NEM), Newcrest Mining (NCMGY), AngloGold Ashanti (AU), and several other industry leaders.